menu
arrow_back
Glioblastoma Multiforme (GBM) Market Share, Size, Analysis, Growth, Trends and Forecast
p class=MsoNormalThe global a href=https://www.hexaresearch.com/research-report/glioblastoma-multiforme-gbm-market?utm_source=bloggalot&utm_medium=referral&utm_campaign=Avinash_14Feb&utm_content=PRglioblastoma multiforme (GBM) market/a growth from 2014 to 2024 will depend on increasing demand for cancer in the central nervous system. The disease is characterized as one of the most aggressive cancer which usually recurs periodically. Typically, a person suffering from glioblastoma survives for around one year, with a marginal survival rate of 3%-5% over five years.span style=font-size: 11.5pt; line-height: 107%; font-family: Arial, sans-serif; color: #333333; letter-spacing: 0.15pt; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; /span&g
keyboard_arrow_up